NCT02820233Recruiting
Studies of Neuregulin/ERBB Signaling in Human Heart
Isolation and Characterization of ERBB Expressing Human Heart Progenitor Cells
Source: ClinicalTrials.gov · Last updated 3 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study examines the role of the epidermal growth factor (EGF) receptor family and the EGF family of ligands in the regulation of non-myocytes isolated from the human heart.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 80 (estimated)
- First submitted
- 27 Jun 2016
- Start date
- Jun 2015
- Primary completion date
- Sept 2028
- Lead sponsor
- Douglas B. Sawyer
- Diseases
- Heart failure
- NCT number
- NCT02820233
What you commit to
- Study type: Observational
- Planned participants: 80
- From Jun 2015 to the primary completion date, Sept 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- constrictive pericarditis or other significant pericardial disease
- severe pulmonary hypertension
- severe ventricular arrhythmias
Lab values
- significant renal impairment (Cr \> 2.5 mg/dL)
Age
- less than 18 years of age
Other
- unwilling or unable to provide informed consent
- known active myocarditis
- hypertrophic cardiomyopathy
- pregnancy
Who the study is looking for
- Clinical diagnosis of severe coronary artery disease scheduled to undergo coronary artery bypass surgery.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Maine Medical Center Coordinator of this site? Confirm its status | Portland | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.